Amneal Pharmaceuticals, Inc. Annual Operating Income (Loss) in USD from 2016 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Amneal Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2016 to 2023.
  • Amneal Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was $95.5M, a 19.2% increase year-over-year.
  • Amneal Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was $175M, a 10.4% decline year-over-year.
  • Amneal Pharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was $204M.
  • Amneal Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$94.9M, a 162% decline from 2021.
  • Amneal Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was $153M, a 67.5% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $204M +$299M Jan 1, 2023 Dec 31, 2023 10-K 2024-03-14
2022 -$94.9M -$248M -162% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-14
2021 $153M +$61.6M +67.5% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-14
2020 $91.2M +$340M Jan 1, 2020 Dec 31, 2020 10-K 2023-03-03
2019 -$249M -$229M -1164% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 -$19.7M -$265M -108% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-01
2017 $245M -$39.8M -14% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-02
2016 $285M Jan 1, 2016 Dec 31, 2016 10-K 2019-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.